BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CASA
3276
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $20.5M | ﹤0.01% |
2,310,860
-128,878
| -5% | -$1.14M |
|
|
AGS
3277
DELISTED
PlayAGS
AGS
| $20.5M | ﹤0.01% |
2,070,016
-93,526
| -4% | -$863K |
|
|
CS
3278
DELISTED
Credit Suisse Group
CS
| $20.5M | ﹤0.01% |
1,951,854
+414,377
| +27% | +$4.4M |
|
|
KINZU
3279
DELISTED
KINS Technology Group Inc. Unit
KINZU
| $20.5M | ﹤0.01% |
2,000,000
| – | – |
|
3280
James Hardie Industries
JHX
$16.5B
| $20.5M | ﹤0.01% |
598,221
-4,668
| -0.8% | -$157K |
|
|
DSSI
3281
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $20.4M | ﹤0.01% |
2,053,010
+114,153
| +6% | +$1.18M |
|
|
HCAR
3282
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
| $20.4M | ﹤0.01% |
+2,112,000
| New | +$20.5M |
|
3283
Donegal Group Class A
DGICA
$721M
| $20.4M | ﹤0.01% |
1,402,815
+227,512
| +19% | +$3.48M |
|
|
LONA
3284
LeonaBio Inc
LONA
$72M
| $20.4M | ﹤0.01% |
199,305
+100,260
| +101% | +$17.5M |
|
3285
ARKO Corp
ARKO
$840M
| $20.4M | ﹤0.01% |
2,217,580
+856,524
| +63% | +$8.72M |
|
3286
Apyx Medical
APYX
$180M
| $20.4M | ﹤0.01% |
1,974,248
-450,163
| -19% | -$4.46M |
|
3287
ACM Research
ACMR
$5.7B
| $20.3M | ﹤0.01% |
595,989
-2,456,934
| -80% | -$67.5M |
|
|
AMPE
3288
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $20.3M | ﹤0.01% |
40,469
+28,622
| +242% | +$15.4M |
|
3289
AquaBounty Technologies
AQB
$4.68M
| $20.2M | ﹤0.01% |
188,369
+119,934
| +175% | +$13.8M |
|
3290
Prelude Therapeutics
PRLD
$360M
| $20.1M | ﹤0.01% |
702,842
+21,117
| +3% | +$752K |
|
3291
Greif Class B
GEF.B
$4.18B
| $20.1M | ﹤0.01% |
339,888
+355
| +0.1% | +$21.4K |
|
3292
Spok Holdings
SPOK
$234M
| $20M | ﹤0.01% |
2,080,629
-1,004,552
| -33% | -$10.7M |
|
|
NIU
3293
Niu Technologies
NIU
$196M
| $20M | ﹤0.01% |
611,283
+16,051
| +3% | +$535K |
|
3294
Cytosorbents Corp
CTSO
$23.7M
| $19.9M | ﹤0.01% |
2,641,166
-187,436
| -7% | -$1.58M |
|
3295
XBiotech
XBIT
$68.3M
| $19.9M | ﹤0.01% |
1,201,597
-155,978
| -11% | -$2.65M |
|
3296
Mid Penn Bancorp
MPB
$971M
| $19.8M | ﹤0.01% |
722,624
+299,975
| +71% | +$8.16M |
|
|
SOHU
3297
Sohu.com
SOHU
$361M
| $19.8M | ﹤0.01% |
1,065,124
+84,881
| +9% | +$1.51M |
|
3298
iShares Core MSCI Europe ETF
IEUR
$9.09B
| $19.8M | ﹤0.01% |
345,565
-3,589
| -1% | -$207K |
|
|
ITIC
3299
Investors Title Co
ITIC
$547M
| $19.8M | ﹤0.01% |
113,328
-3,552
| -3% | -$618K |
|
|
PRTK
3300
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $19.8M | ﹤0.01% |
2,897,320
-581,120
| -17% | -$4.7M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.